UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1826
Sabre
SABR
$767M
| $3.85M | ﹤0.01% |
1,219,216
+379,709
| +45% | +$974K |
2014 Q2
44 quarters
|
|
1827
DELISTED
Stellar Bancorp
STEL
| $3.85M | ﹤0.01% |
137,433
+50,898
| +59% | +$1.35M |
2021 Q4
14 quarters
|
|
1828
DELISTED
89bio
ETNB
| $3.84M | ﹤0.01% |
391,410
+122,612
| +46% | +$1.02M |
2023 Q3
7 quarters
|
|
1829
Triumph Financial Inc
TFIN
$1.49B
| $3.83M | ﹤0.01% |
69,553
+21,151
| +44% | +$1.18M |
2023 Q1
9 quarters
|
|
1830
Ducommun
DCO
$2.58B
| $3.81M | ﹤0.01% |
46,074
+17,746
| +63% | +$1.18M |
2022 Q4
10 quarters
|
|
1831
Amneal Pharmaceuticals
AMRX
$6.93B
| $3.81M | ﹤0.01% |
470,432
+135,476
| +40% | +$1.02M |
2024 Q1
5 quarters
|
|
1832
Peabody Energy
BTU
$3.06B
| $3.81M | ﹤0.01% |
283,555
+120,608
| +74% | +$1.59M |
2021 Q1
17 quarters
|
|
1833
Intuitive Machines
LUNR
$2.13B
| $3.8M | ﹤0.01% |
349,908
+221,264
| +172% | +$2.17M |
2025 Q1
1 quarter
|
|
1834
Under Armour Class C
UA
$2.05B
| $3.79M | ﹤0.01% |
583,635
+91,294
| +19% | +$539K |
2016 Q2
36 quarters
|
|
1835
Integra LifeSciences
IART
$1.05B
| $3.78M | ﹤0.01% |
308,139
+63,804
| +26% | +$926K |
2013 Q2
48 quarters
|
|
1836
Interface
TILE
$2.01B
| $3.77M | ﹤0.01% |
180,259
+28,309
| +19% | +$561K |
2013 Q2
48 quarters
|
|
1837
Carter's
CRI
$1.19B
| $3.77M | ﹤0.01% |
125,030
+4,066
| +3% | +$138K |
2013 Q2
48 quarters
|
|
1838
Globant
GLOB
$1.57B
| $3.76M | ﹤0.01% |
41,388
+17,641
| +74% | +$1.88M |
2019 Q2
24 quarters
|
|
1839
Aurinia Pharmaceuticals
AUPH
$2.22B
| $3.76M | ﹤0.01% |
443,578
+284,431
| +179% | +$2.28M |
2019 Q2
24 quarters
|
|
1840
Eldorado Gold
EGO
$9.82B
| $3.75M | ﹤0.01% |
184,123
+10,425
| +6% | +$203K |
2024 Q2
4 quarters
|
|
1841
DELISTED
NV5 Global
NVEE
| $3.74M | ﹤0.01% |
162,161
+44,391
| +38% | +$888K |
2020 Q3
19 quarters
|
|
1842
Ellington Financial
EFC
$1.5B
| $3.73M | ﹤0.01% |
286,938
+107,135
| +60% | +$1.36M |
2019 Q4
22 quarters
|
|
1843
Virtus Investment Partners
VRTS
$869M
| $3.71M | ﹤0.01% |
20,427
+4,197
| +26% | +$698K |
2017 Q1
33 quarters
|
|
1844
Pennant Group
PNTG
$1.39B
| $3.7M | ﹤0.01% |
124,077
+42,685
| +52% | +$1.17M |
2023 Q1
9 quarters
|
|
1845
Infosys
INFY
$43.5B
| $3.7M | ﹤0.01% |
199,609
+159,267
| +395% | +$2.84M |
2013 Q2
48 quarters
|
|
1846
Xerox
XRX
$361M
| $3.69M | ﹤0.01% |
700,692
+100,674
| +17% | +$491K |
2013 Q2
48 quarters
|
|
1847
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.69B
| $3.69M | ﹤0.01% |
137,439
-1,859,977
| -93% | -$48.2M |
2017 Q2
32 quarters
|
|
1848
STAAR Surgical
STAA
$1.09B
| $3.68M | ﹤0.01% |
219,179
+95,832
| +78% | +$1.69M |
2018 Q2
28 quarters
|
|
1849
QCR Holdings
QCRH
$1.59B
| $3.66M | ﹤0.01% |
53,890
+11,111
| +26% | +$743K |
2020 Q4
18 quarters
|
|
1850
HCI Group
HCI
$2.38B
| $3.66M | ﹤0.01% |
24,024
+7,330
| +44% | +$1.13M |
2023 Q1
9 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.